PetIQ Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PetIQ stock.
View analyst ratings for PetIQ or view top-rated stocks.

Wall Street analysts have given PetIQ a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PetIQ wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for PetIQ.

PetIQ will be holding an earnings conference call on Thursday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

PetIQ, Inc. (NASDAQ:PETQ) issued its quarterly earnings data on Tuesday, March, 10th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.09 by $0.18. The firm earned $154.34 million during the quarter, compared to the consensus estimate of $134.80 million. PetIQ had a negative net margin of 10.13% and a positive trailing twelve-month return on equity of 4.47%.
View PetIQ's earnings history.

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ shares have increased by 57.1% and is now trading at $35.50.
View which stocks have been most impacted by COVID-19.

4 equities research analysts have issued twelve-month price objectives for PetIQ's shares. Their forecasts range from $35.00 to $175.00. On average, they anticipate PetIQ's stock price to reach $76.25 in the next twelve months. This suggests a possible upside of 114.8% from the stock's current price.
View analysts' price targets for PetIQ or view top-rated stocks among Wall Street analysts.

10 employees have rated PetIQ CEO Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among PetIQ's employees.

Some companies that are related to PetIQ include Nu Skin Enterprises (NUS), (BTCA) (BTCA), Trxade Group (TRXD), Trxade Group (MEDS), Bioasis Technologies (BIOAF), China Medicine (CHME), Medizone International (MZEIQ), ScripsAmerica (SCRCQ) and China BCT Pharmacy Group (CNBI).
View all of PETQ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.47%), Russell Investments Group Ltd. (4.50%), Riverbridge Partners LLC (4.23%), Yiheng Capital Management L.P. (2.39%), Thornburg Investment Management Inc. (2.18%) and Peregrine Capital Management LLC (1.60%). Company insiders that own PetIQ stock include James Nathan Clarke, John Newland, Robert Michael Herrman, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ.

PETQ stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Assenagon Asset Management S.A., Peregrine Capital Management LLC, Royce & Associates LP, Rothschild & Co. Asset Management US Inc., AMI Asset Management Corp, Argent Capital Management LLC, and Citigroup Inc.. Company insiders that have sold PetIQ company stock in the last year include John Newland, and Will Santana.
View insider buying and selling activity for PetIQ or view top insider-selling stocks.

PETQ stock was purchased by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., Riverbridge Partners LLC, Russell Investments Group Ltd., Morgan Stanley, BlackRock Inc., Kiwi Wealth Investments Limited Partnership, First Trust Advisors LP, and Vontobel Holding Ltd.. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ or or view top insider-buying stocks.

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETQ stock can currently be purchased for approximately $35.50.

PetIQ has a market capitalization of $1.02 billion and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis.

PetIQ employs 1,866 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ is headquartered at 923 S. Bridgeway Pl., EAGLE ID, 83616.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]